FDA, FTC team up on STD warning letter
This article was originally published in The Tan Sheet
Telledant LLC of Culver City, Calif., receives a warning letter from FDA and the Federal Trade Commission regarding a range of products marketed under the Biogetica brand. Products claiming natural relief from sexually transmitted diseases, such as the "Deliverance from Herpes Kit" and "Chlamydia Venereal Mix Formula," are unapproved drugs under the FDC Act. The firm also lacks competent and reliable scientific evidence to support their claims, the Sept. 28 letter says. The agencies collaborated on a warning letter regarding alleged swine flu claims in 2009 (1"The Tan Sheet" Oct. 19, 2009)
You may also be interested in...
A warning letter sent jointly by FDA and the Federal Trade Commission takes a double-pronged approach toward cracking down on a supplement marketer's claims regarding the H1N1 flu virus
Increasing clinical trial complexity goes hand in hand with increased reliance on advanced-analysis software. Raj Indupuri of eClinical Solutions believes the company's product will lead this emerging market.
Merck KGaA’s short-course oral MS therapy Mavenclad may gain a boost from new data suggesting its use does not affect the beneficial response of patients to COVID-19 vaccines, as the research and manufacturing reagents and solutions business unit of the diversified big pharma reported a strong first quarter due to pandemic-related demand.